Navigation Links
Biota Initiates Drug Testing War against Common Cold

Human clinical trials of BTA798 anti-viral therapy for common cold have been initiated by Biota. The compound has already proven to be effective against the human rhinovirus // in lab experiments conducted on animal models. HRV currently accounts for nearly 50% and 75% of common cold suffered by adults and children respectively.

If successful results are obtained, the drug would soon be marketed. The researchers have however warned that it may not be a suitable treatment modality for everyone as common cold usually manifests as a self-limiting disease in healthy individuals. In addition, anti-viral medications are expensive compared to commonly used anti-biotics.

Patients who develop complications as a result of cold and other concommitant diseases would benefit the maximum from the new therapy. Examples include asthmatics, patients with chronic obstructive pulmonary disease (COPD), those undergoing chemotherapy or radiotherapy and immunocompromised individuals (HIV/AIDS patients, transplant recipients).

It has been found from U.S. statistical studies that 45 million bed days in hospitals could be atrributed to individuals who developded disease related complications as a result of common cold. It would be more sensible for these individulas to invest a few dollars for fighting the common cold rather than spending a considerble amount on hospital admission.

The health officials of Biota have remarked that the initiation of the first, independent clinical trial in Britain marked an important milestone in the company history. The results of the much-awaited trial would be released by December.


'"/>




Page: 1

Related medicine news :

1. Bird Flu: Orissa Initiates Protective Measures
2. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
3. Government Initiates A Program To Curb HIV
4. First Vaccine Designed for Africa Cleared for Testing in Humans
5. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
6. Testing for blood sugar levels made easier
7. DNA Testing For More Accurate Results
8. SARS vaccine shows promise in Animal Testing
9. Testing Of Saliva May Predict Dental Caries
10. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
11. Testing genes for disease does not cause harm to children of people with Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: